Daily Care News from 1996
- Diabetic Ketoacidosis and Cerebral Edema by Elliot J. Krane, M.D., Departments of Pediatrics and Anesthesiology, Stanford University Medical Center, describes why the cerebral complications of DKA are the most common cause of diabetic-related death of young diabetic patients.
- Exercise: An Alternative Therapy for Gestational Diabetes offers advice on managing gestational diabetes. From The Physician and Sportsmedicine, Vol 24 , No. 3, March 1996.
- Glycohemoglobin testing is discussed in detail in the April 1997 issue of Diabetes Forecast.
- The Safety of Injecting Insulin Through Clothing (from Diabetes Care, Volume 20 Number 3, March 1997)
- A study on Diabetic Ketoacidosis Charges Relative to Medical Charges of Adult Patients With Type 1 Diabetes shows that "DKA episodes represented more than $1 of every $4 spent on direct medical care for adult patients with type I diabetes and $1 of every $2 in those patients experiencing multiple episodes." (from Diabetes Care, Volume 20 Number 3, March 1997)
- Researchers compare injection site effects of Insulin Lispro and Regular Insulin (from Diabetes Care, Volume 19, Number 12, December 1996)
- Home Blood Glucose Monitors Fail Tests (9 Dec 96)
- Accuracy of home blood glucose meters during hypoglycemia not up to ADA recommendations. (from Diabetes Care, Volume 19, Number 12, December 1996)
- ADA to continue support for camps for kids with diabetes. (8 Dec 96)
- U.S. Federal Trade Commission says companies cannot claim benefit from chromium picolinate supplement.
- A1c Is Our Best Outcome Measure: Let's Use It, from Clinical Diabetes, Volume 14, No. 4, July/August 1996.
- Intensive Treatment of Diabetes Pays Off (8 November 1996)
- New Guidelines for Mother and Child Before and After Diabetic Pregnancy (dated 10 June 1996)
- Novo Nordisk files suit against Eli Lilly over Lilly's marketing of new insulin cartidges. (1 August 1996)
- The Wait is Over is an article from Diabetes Forecast about Humalog®, the new fast acting insulin analog from Eli Lilly.
- Lilly's Humalog -- First New Insulin in 14 Years -- Approved for Marketing by U.S. Food and Drug Adminstration (17 June 1996)
- Amylin Pharmaceuticals Completes Enrollment in Clinical Trials of Diabetes Drug Candidate (12 June 1996)
- MiniMed announces their latest insulin pump, the MiniMed 507 (12 June 1996)
- Lilly's Humalog Recommended for FDA Marketing Clearance (29 February 1996)
- Humalog Approved by the European Medicine Evaluation Agency (2 May 1996)
Current Daily Care News |
Last Updated: Thursday January 01, 2015 15:28:56
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.